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ABSTRACT Clinical interventions in the stomach have been linked to fecal microbi-
ota alterations, suggesting a function of the stomach in gastrointestinal (GI) homeo-
stasis. We sought to determine the taxonomic bacterial biogeography of the upper
GI tract, including different sites within the human stomach (cardia, corpus, and an-
trum), adjacent upstream (esophagus) and downstream (duodenum) locations, and
luminal contents (aspirate), as well as whole-stomach samples from mice and gerbils.
Qualitative and quantitative DNA- and RNA-based taxonomic microbiota analyses
were combined to study the relationship of relative and absolute bacterial abun-
dances and transcriptionally active bacterial microbiota components in the stomach
of humans and mice. Stomach microbiota compositions resembled those of esopha-
gus and duodenum. However, along the descending GI tract, the relative abun-
dances of speciﬁc oropharyngeal commensals decreased (Streptococcus) or increased
(Rothia mucilaginosa, Porphyromonas, and Lachnospiraceae). Furthermore, the com-
positional similarity (weighted UniFrac) between stomach aspirates and esophageal
biopsy samples increased with gastric Streptococcus relative abundance. In both hu-
man aspirate and mouse stomach samples, Firmicutes were more abundant among
transcriptionally active bacteria than Bacteroidetes. The relative abundance of Firmic-
utes in the stomach was negatively correlated and that of Bacteroidetes was posi-
tively correlated with absolute bacterial abundance, suggesting a disproportionate
increase of Bacteroidetes over Firmicutes at higher bacterial densities. Human, mouse,
and gerbil stomach samples showed similarities at higher taxonomic levels but dif-
ferences at lower taxonomic levels. Our ﬁndings suggest selective enrichment and
depletion of speciﬁc bacterial taxa in the stomach and Firmicutes being transcrip-
tionally more active than Bacteroidetes that increase in relative abundance with total
bacterial load.
IMPORTANCE Clinical stomach interventions, such as acid inhibition or bypass sur-
gery, have been linked to fecal microbiota alterations. We demonstrate that the
stomach microbiota largely overlaps those of adjacent gastrointestinal locations and
identify gradual decreases and increases in the relative abundances of speciﬁc bac-
teria within the stomach, suggesting selective enrichment and depletion. Moreover,
similarities between stomach and esophagus samples are proportional to the con-
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centrations of Streptococcus (Firmicutes) in the stomach. The relative abundance of
Firmicutes in the stomach, compared to that of Bacteroidetes, is increased in RNA rel-
ative to DNA, indicating higher transcriptional activity. Moreover, increased absolute
bacterial loads are associated with decreased relative abundance of Firmicutes and
higher relative abundance of Bacteroidetes. Our ﬁndings characterize the stomach
microbiota as inﬂuenced by Bacteroidetes inﬂux against a background of transcrip-
tionally more active Firmicutes. Human, mouse, and gerbil stomach microbiotas differ
at lower taxonomic levels, which might affect the utility of these model organisms.
KEYWORDS 16S rRNA, absolute abundance, quantitative microbiota analysis,
stomach microbiota, transcriptional activity
The systemic relevance of the gastrointestinal (GI) microbiota for human health hasbeen widely documented in the scientiﬁc literature. Speciﬁc microbiota features
have been linked to the risk for and recovery from infectious diseases (1–4) and diverse
metabolic (5–7) and immunological disorders, including autoimmunity and allergies
(8–10), as well as malignant diseases (11, 12) and even neurological conditions (13).
Microbiota projects typically focus on fecal samples as a proxy for the gastrointestinal
microbiome, although differences in microbial density, diversity, and composition
between the small and large intestine and between the luminal and mucosa-adherent
microbiota have been reported (14–16). The stomach has received less attention than
the intestine, despite the reports from recent studies that linked gastric surgical and
medical interventions to alterations of the fecal microbiota and associated clinical
features: Roux-en-y gastric bypass surgery altered the lower intestinal microbiota in
mice, with beneﬁcial metabolic effects on the host that were transferable by microbiota
transplantation to germfree mice (17), and similar effects were shown in humans (18,
19). Suppression of gastric acid production by proton pump inhibitors is associated
with increased risk for Clostridium difﬁcile infection (20) and has been demonstrated to
alter fecal microbiota compositions in humans (21, 22). An improved understanding of
the gastric microbial ecosystem therefore has the potential to generate new means to
inﬂuence gut homeostasis, with potentially far-reaching systemic health consequences.
The perspective on the stomach microbiota has considerably changed over the last
decades. Originally considered sterile due to the harsh acidic and proteolytic environ-
ment, the stomach is now assumed to harbor diverse bacterial and fungal communities
at the mucosa and in luminal ﬂuid, in addition to the prominent gastric pathogen
Helicobacter pylori (23–25). Compositional differences among gastric, oral, and throat
microbiota (26) have been interpreted as indicators for the existence of distinct
microbial communities that include adapted, residual bacteria in the stomach (23).
However, conclusive evidence for a metabolically active unique gastric microbiota is
difﬁcult to provide by 16S rRNA gene amplicon sequencing-based microbiota analysis
alone.
The stomach differs from adjacent up- and downstream locations of the GI tract with
respect to pH (27) and mucosal architecture, and separate sections within the stomach
display additional histological variation (Fig. 1). While the esophagus is lined by a
stratiﬁed multilayered squamous epithelium, a single layer of columnar epithelial cells
covers the stomach and duodenum, the latter specifying the beginning of the small
intestine. Within the stomach, three different histological regions, cardia, corpus, and
antrum, can be distinguished based on the composition of epithelia and glands and on
the cellular proﬁles of secretory compounds. Gastric acid and pepsinogen are produced
exclusively in the corpus region via oxyntic glands, whereas speciﬁc mucins are
produced in cardia and antrum, and all locations vary with respect to the presence of
endocrine- and antimicrobial peptide-producing cells (28, 29). Intriguingly, each of the
individual stomach regions is affected by a distinct set of diseases, which have been
associated with speciﬁc microbiota alterations (30–34). Mice and gerbils are two
commonly used rodent models of human stomach pathology (35). However, in addi-
tion to the glandular region, which is outlined by a simple columnar epithelium and is
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similar to the human stomach, rodents have a nonglandular forestomach, which
provides storage and mechanical food digestion (36). Nevertheless, well-deﬁned
boundaries separate the stratiﬁed squamous epithelium of the esophagus from both
the glandular stomach in humans and the forestomach in rodents (36).
Previous studies on the human stomach microbiota found signiﬁcant differences
between gastric mucosal biopsy samples and ﬂuid aspirate samples (37), with the
former being dominated by H. pylori in colonized individuals (38–40) and the latter
containing commensal microorganisms from the throat and mouth (41–43). Studies
comparing microbiota compositions based on isolated DNA or RNA found parts of the
gastric microbiota to display transcriptional activity in the stomach (44), which could
indicate resilience or even adaptation of speciﬁc bacterial taxa to the harsh environ-
ment of the stomach. H. pylori colonization, pH, and immunosuppression were linked
to differences in gastric microbiota compositions (44).
Here we sought to generate a high-resolution map of the microbiota of the human
stomach, including detailed comparisons of clinically and histologically different gastric
locations (cardia, corpus, and antrum) and samples associated with the gastric lining
and luminal contents (biopsy samples and aspirates) and adjacent sites that are located
up- and downstream of the stomach (esophagus and duodenum). Gastric microbiota
compositions were analyzed in the context of two clinically and geographically distinct
human cohorts and compared to those of mice and gerbils. To explore the relationship
of the total gastric bacterial microbiota that can be identiﬁed in the stomach and that
may include dead and inactive bacteria and the fraction of the microbiota that retains
transcriptional activity, additional 16S rRNA gene and transcript amplicon sequencing
was carried out on a small set of human gastric aspirate and mouse whole-stomach
samples. Combined qualitative and quantitative bacterial microbiota analyses of these
samples were used to compare relative and absolute abundances of speciﬁc bacterial
phyla.
We demonstrate signiﬁcant interindividual variations in human and animal gastric
microbiota compositions, independent of host disease status, and enrichment and
FIG 1 Histology and locations of the sampled human upper GI tract sections. (A) Gastroesophageal
junction, showing the stratiﬁed multilayered squamous epithelium of the esophagus (Es) and the single
layered columnar epithelium of the gastric cardia region (Ca). (B) Stomach corpus (Co) mucosa with
oxyntic gastric glands. (C) Stomach antrum (An) with mucous glands in the mucosa. (D) Small-bowel
architecture with villi and crypts of the duodenum (Du). (E) Schematic overview, including gastric aspirate
(As). Abbreviations: s, surface; m, mucosa. Magniﬁcations, 40 (A and B) and100 (C and D).
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depletion of speciﬁc bacterial taxa along the descending axis of the upper human GI
tract. Further, 16S rRNA transcript analysis indicates a relatively larger contribution of
bacteria from the phylum Firmicutes than of bacteria from Bacteroidetes to the tran-
scriptionally active stomach microbiota and that interindividual variation in the relative
abundances of these two bacterial groups appears to be largely driven by differences
in the absolute abundance of Bacteroidetes alone.
RESULTS
Patient population and sample types. A diverse patient population was enrolled
in this study, including asymptomatic patients and individuals with various GI pathol-
ogies, who underwent diagnostic and surveillance upper GI tract endoscopy, respec-
tively. A summary of the clinical patient information is provided in Table 1, and a
detailed description of the sample metadata is presented as part of the supplemental
material (see Table S1 in the supplemental material). To study the spatial organization
of the stomach microbiota, separate topographic locations representative of speciﬁc
mucosal architectures were sampled (Fig. 1). Specimens consisted of gastric ﬂuid
aspirate and biopsy samples from the esophagus, the esophageal-gastric junction
(cardia), the gastric corpus and antrum, and the duodenum (small intestine). Specimens
were analyzed by 16S rRNA gene amplicon sequencing, which on average generated
3,515 reads corresponding to 98 operational taxonomic units (OTUs) per sample (see
Table S2 and Fig. S1 in the supplemental material for overviews of sequence data and
taxonomic microbiota composition).
Stomach microbiota in relation to esophagus and duodenum. Based on phylo-
genetic (unweighted/weighted UniFrac) and other (Bray-Curtis) distance metrics, stom-
ach, esophagus, and duodenum samples clustered by individual (P 0.001) rather than
by specimen location (P 0.1) (Fig. 2A and B). For all locations and specimen types,
microbiota compositions were dominated by the phylum Firmicutes (73.2  1.2%),
followed by Bacteroidetes (12.5  0.9%), Actinobacteria (9.4  0.6%), and Proteobacteria
(2.9  0.4%) (Fig. 2C), except in two patients with H. pylori gastritis (P13 and P14), as
diagnosed histologically and by immunostaining. For these H. pylori-positive patients,
in agreement with the preferred mucosal niche of this stomach-adapted bacterium,
gastric biopsy samples but not aspirate or esophageal biopsy samples contained high
relative abundances of H. pylori, with 0.5% (esophagus), 95% (corpus and antrum),
22% (cardia), and 5% (gastric aspirate) of all reads assigned to this bacterium
TABLE 1 Patient population and analyzed samplesa
Patient
Age
(yrs) Sex Disease category Collected samples
P01 68 F GERD E, Ca, Co, An, D, As
P02 21 F IBD (Crohn’s disease) E, Ca, Co, An, As
P03 61 M Normal Ca, Co, An, As
P04 38 F Normal E, Ca, Co, An, D, As
P05 23 F Normal E, An, D, As
P06 20 F Normal E, Co, D, As
P07 29 F Normal E, An, D, As
P08 68 M Atrophic autoimmune gastritis Ca, Co, An, As
P09 47 F Normal E, Ca, An, D
P10 54 F Normal E, Co, An, D, As
P11 24 F Normal E, Ca, An, D, As
P12 71 F Normal E, Ca, Co, An, D, As
P13 61 M Helicobacter pylori gastritis E, Ca, Co, As
P14 56 F Helicobacter pylori gastritis E, An, As
P15 54 M Normal As
P16 27 F Normal As
P17 39 F Atrophic autoimmune gastritis As
aAbbreviations: F, female; M, male; GERD, gastroesophageal reﬂux disease; IBD, inﬂammatory bowel disease;
E, esophagus; Ca, cardia; Co, corpus; An, antrum; D, duodenum; As, aspirate. E, Ca, Co, An, and D were
collected as biopsy samples. Disease categories are based on histological diagnosis of the stomach. See
Table S1 for additional information.
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FIG 2 Mucosal microbiota analysis of the human stomach in relation to esophagus and duodenum. (A and B) Principal-coordinate analysis (PCoA) plots of
microbiota comparisons of biopsy samples based on taxonomic distance (unweighted UniFrac), showing signiﬁcant differences between patients (A) but not
between sampled locations (B). Signiﬁcance was determined with a nonparametric analysis of similarity (ANOSIM) test, using 999 permutations, as implemented
in QIIME (64). (C) Mean relative microbiota compositions of all upper GI samples at the taxonomic order and phylum levels, including all OTUs with1% relative
abundance in at least one sample, excluding samples from H. pylori-positive patients. (D) Cladogram showing bacterial taxa with differential relative
(Continued on next page)
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(Fig. S2; the duodenum was not sampled from these individuals). In addition to those
patients, 20 of 60 samples from 15 patients not diagnosed as H. pylori positive
contained H. pylori at relative abundances of 0.016% to 3.632%, suggesting low-level
colonization in these individuals.
A comparison of the individual stomach locations showed neither signiﬁcant differ-
ences in overall taxonomic microbiota composition (without samples from H. pylori-
positive patients; Fig. 2A and B) nor signiﬁcant differences in microbial diversity
(Shannon/Simpson indices, excluding samples from H. pylori-positive patients; Fig. S3A
and B). While microbial diversity tended to be increased in gastric compared to
esophageal biopsy samples from H. pylori-negative patients (P 0.05, based on Shan-
non/Simpson indices [not signiﬁcant for rarefaction analysis]) but not compared to
gastric and duodenal biopsy samples (Fig. S3C and D), four bacterial groups with a
mean relative abundance of 0.1% showed signiﬁcant differences between stomach
and esophageal biopsy samples (linear discriminant analysis [LDA] score of 2.0)
(Fig. 2D). Mean relative abundances of the genus Streptococcus were decreased (68.0
5.2% versus 53.8  2.3%) (LDA 4.9, P 0.014) and those of the species Rothia
mucilaginosa (1.62  0.42% versus 3.48  0.44%) (LDA 4.0, P 0.018), the genus
Porphyromonas (0.86  0.3% versus 1.73  0.35%) (LDA 3.7, P 0.034), and the
family Lachnospiraceae (0.39  0.14% versus 0.74  0.1%) (LDA 3.3, P 0.037) were
increased in stomach compared to esophagus biopsy samples. R. mucilaginosa abun-
dances were also increased in duodenum compared to esophagus biopsy samples,
whereas no differences were detected between stomach and duodenum samples.
Those bacterial taxa with different overall stomach and esophagus relative abundances
also displayed gradual changes within the stomach (Fig. 3). The relative abundance of
Streptococcus continually decreased (Spearman’s rank correlation coefﬁcient, R 
0.46, P 0.005) along the GI axis, i.e., from esophagus to cardia, corpus, and antrum,
whereas those of R. mucilaginosa, Porphyromonas, and Lachnospiraceae continually
increased (R 0.39, P 0.02). If duodenal biopsy samples were included in the analysis,
the strength of correlation between increasing or decreasing relative abundances and
progression along the GI tract would be reduced for all four taxa (Fig. 3).
The human gastric aspirate samples exhibited levels of microbial diversity (Fig. S3A
and B) and taxonomic compositions (Fig. 2C) similar to those seen with the biopsy
samples, but the dominance of Firmicutes and Bacteroidetes over the entire microbiota
was even more pronounced for gastric ﬂuid samples (mean, 87.7  1.4%) than for
biopsy samples (mean, 83.5  1.1%) (Fig. 4A). Relative abundance ranges differed
substantially between individuals (for Firmicutes, 53.1% to 86.1%; for Bacteroidetes, 0.2%
to 35.5%) but were not signiﬁcantly linked to patient health status (Fig. 4B). Reanalysis
of a previously published gastric aspirate data set from a heterogeneous patient cohort
(44) showed similar degrees of variation irrespective of patient health status (Fig. 4B;
P 0.1 for all data combined [Kruskal-Wallis rank sum test]).
Relationship of stomach and adjacent microbiota. To study the relationship
between the microbiota of esophagus and stomach, pairs of human esophageal biopsy
and gastric ﬂuid samples were compared and the similarities in microbiota composition
calculated based on phylogenetic distance (weighted UniFrac). Gastric aspirate samples
were selected for this analysis, as the aspirate microbiota was expected to be more
strongly inﬂuenced by microbial inﬂux from upstream GI locations than the mucosal
microbiota from biopsy samples. Phylogenetic distances between gastric ﬂuid and
esophagus microbiota pairs were negatively correlated with the relative abundance of
the most abundant member of the gastric microbiota, i.e., the phylum Firmicutes
FIG 2 Legend (Continued)
abundances, from kingdom (innermost ring) to species (outermost ring), between esophagus and stomach biopsy samples from H. pylori-negative patients,
using a linear discriminant analysis (LDA) effect size of 2.0 as determined with LEfSe (65). Circle diameters used to represent taxa are proportional to their
relative abundances. Circle colors indicate a signiﬁcant increase in esophagus samples (red) or in stomach samples (green) or no difference between the two
sample types. Shaded circle fractions in red and green mark the lower taxonomic groups that comprise each taxon with signiﬁcantly different relative
abundances in the two sample groups.
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FIG 3 Changes in relative abundance of speciﬁc bacterial taxa along the descending axis of the human upper GI tract.
Relative abundances of bacterial taxa with a mean relative abundance of 0.1% and an LDA effect size of 2.0 for the
LEfSe comparison of stomach and esophagus biopsy samples from H. pylori-negative patients (Fig. 2D) were analyzed.
Correlations were determined separately from esophagus to antrum (black lines) and from esophagus to duodenum (red
lines), using the two-tailed, nonparametric Spearman’s rank correlation coefﬁcient test.
FIG 4 Firmicutes and Bacteroidetes in human gastric aspirate samples. (A) The relative dominance of
Firmicutes and Bacteroidetes over the gastric microbiota was more pronounced in gastric aspirate samples
than in biopsy samples, as demonstrated by the results of comparisons of combined fractions performed
using the nonparametric Mann-Whitney U test (*, P 0.05). (B) Variations in the relative abundances of
Firmicutes and Bacteroidetes among gastric aspirate samples are apparently not linked to patient disease
status. Symbols represent samples from individuals with different disease backgrounds from two
separate studies, i.e., data from this study (outlined symbols) and a previously published data set (44),
including H. pylori (HP)-positive and-negative patients.
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(Spearman R  0.76, P 0.0003) or the genus Streptococcus (Spearman R  0.64,
P 0.006) (Fig. 5). In other words, a higher relative abundance of Firmicutes or Strep-
tococcus in gastric ﬂuid was associated with a higher level of microbiota composition
similarity of gastric ﬂuid to esophageal biopsy samples.
Comparison of human, mouse, and gerbil gastric microbiotas. To compare the
human stomach microbiota to that of two animal models for gastric disease, whole-
stomach samples from healthy adult individually housed or cohoused mice and gerbils
were included in the analysis (see Table S1 for animal background). Gastric samples
clustered by host (unweighted/weighted UniFrac, Bray-Curtis distance, P 0.001)
(Fig. 6A; see also Fig. S4A and B) and showed increased microbial diversity in humans
compared to animals (Simpson/Shannon index; Fig. 6B; not signiﬁcant for rarefaction
analysis, Fig. S4C). Human and animal samples were dominated by the same two
bacterial phyla, classes, and orders (Firmicutes, Bacilli, Lactobacillales and Bacteroidetes,
Bacteroidia, Bacteroidales) (Fig. 6C). However, human samples mostly contained Strep-
tococcus (59.5  13.5%) and Prevotella (12.9  2.2%), whereas mouse and gerbil
samples were dominated by Lactobacillus (81.9 13.8%) and an unknown genus of the
family Muribaculaceae (formerly S24-7; 8.5  1.9%). Animal samples showed interindi-
vidual variations in the relative abundances of Firmicutes and Bacteroidetes similar to
those seen in human samples (Fig. 6D). While the animal sample numbers were too low
for statistical analysis, no obvious link was apparent between Firmicutes and Bacte-
roidetes relative abundance and animal age, sex, genetic relationship, or caging con-
dition (Table S1).
16S rRNA gene- and transcript-based quantitative stomach microbiota analy-
sis. An additional set of seven human gastric aspirate and six mouse whole-stomach
samples was analyzed by 16S rRNA gene and transcript amplicon sequencing and
quantitative 16S rRNA gene PCR (Table S1). This secondary study was conceived to
demonstrate the feasibility of a quantitative assessment of the total and transcription-
ally active bacterial fraction within the stomach microbiota and to support ﬁndings
from the primary data set.
Metagenomic DNA and metatranscriptomic RNA were simultaneously isolated from
speciﬁc and comparable sample quantities. Exactly the same bacterial lysis protocol
was applied for DNA and RNA isolation, and two technical replicates were processed
per sample (Fig. S5). Relative taxonomic microbiota compositions were determined by
16S rRNA gene or transcript amplicon sequencing to a minimum depth of 10,000 reads
per sample (Table S2). The yields of extracted DNA and RNA and of quantitative 16S
rRNA gene copies and transcripts, as determined by 16S rRNA-speciﬁc PCR or reverse
transcription-PCR (RT-PCR), were normalized to data from 1ml of gastric aspirate, in
order to compare analysis results from different human individuals. For mice, nucleic
FIG 5 Relationship of human stomach and esophagus microbiota. Analyses of correlations of taxonomic
distances (weighted UniFrac) between gastric aspirate and esophageal biopsy samples with the relative
abundances of the phylum Firmicutes (A) or the genus Streptococcus (B) in aspirate samples were
performed on the basis of Spearman’s (two-tailed) rank correlation coefﬁcient analysis. Each bar shows
the relative abundance of Firmicutes (A) or Streptococcus (B) of an individual aspirate sample, as well as
the range of taxonomic distances found between the microbiota of this sample and all esophagus biopsy
samples, including samples from H. pylori-positive and -negative patients.
Wurm et al.
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acid yields and 16S rRNA gene copy and transcript numbers were normalized to data
from one complete mouse stomach (see Materials and Methods for details). Among all
parameters, mean values from two replicates were used for subsequent analyses.
On average, human gastric aspirate contained 324 ng DNA ( 76.2), including
7 108 16S rRNA gene copies ( 6.6 108), and 429 ng RNA ( 143.2), including
3 107 16S rRNA transcripts ( 1.9 107), per ml of aspirate, compared to 4.5 g DNA
( 1.08), including 3 109 16S rRNA gene copies ( 1.1 109), and 13.0 g RNA
( 4.39), including 4 108 16S rRNA transcripts ( 2.2 108), per mouse stomach.
Total yields of DNA and RNA, as well as of 16S rRNA gene copies and transcripts per
milliliter of human gastric aspirate and mouse whole-stomach samples, were positively
correlated, and so were DNA yield and 16S rRNA gene copies (all P 0.05 [Spearman’s
FIG 6 Microbiota comparison of H. pylori-negative human, mouse, and gerbil stomach samples. (A) Taxonomic
microbiota compositions differ between humans (aspirate plus biopsy samples), mice, and gerbils, as determined
with nonparametric ANOSIM tests, using 999 permutations, based on taxonomic distance (unweighted UniFrac). (B)
Microbial diversity comparison using Shannon and Simpson indices, with signiﬁcance determined based on a
nonparametric two-sample t test, using 999 Monte Carlo permutations and Bonferroni correction for multiple
comparisons (**, P 0.01). (C) Mean relative microbiota compositions at the genus and phylum levels, including all
OTUs with 1% relative abundance in at least one group of samples (human, mouse, or gerbil). (D) Variations in
the relative abundances of Firmicutes (Firm.) and Bacteroidetes (Bact.) among human, mouse, and gerbil samples.
Actino., Actinobacteria; HA, human aspirate; HB, human biopsy; G, gerbil; M, mouse; uncl., unclassiﬁed.
Biogeography of the Stomach Microbiota
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rank correlation]) but not RNA yield and number of 16S rRNA transcripts (P 0.05;
Fig. S6). Human and mouse samples contained on average 9.3-fold more 16S rRNA
gene copies than transcripts.
In agreement with the primary data set, Firmicutes and Bacteroidetes represented the
two most abundant bacterial taxa in DNA and RNA extracts from both human and
mouse stomach samples (Table S2). However, in contrast to previously reported
ﬁndings from our group (44), the direct comparison of DNA- and RNA-based taxonomic
microbiota compositions in all human and mouse samples revealed a higher relative
abundance of Firmicutes and Actinobacteria and a reduced relative abundance of
Bacteroidetes and Proteobacteria among 16S rRNA transcripts compared to 16S rRNA
gene copies (Fig. 7A). As an additional indicator of transcriptional activity, we also
calculated the ratio of absolute 16S rRNA transcript numbers to gene copy numbers
(Fig. 7B). This ratio differed signiﬁcantly between bacterial phyla, ranging from 0.51 
0.34 16S rRNA transcripts per gene copy in Firmicutes to 0.18  0.16 16S rRNA
transcripts per gene copy in Bacteroidetes.
Interestingly, a higher total bacterial abundance, based on 16S rRNA gene copy
number, in gastric human and mouse samples was associated with decreased relative
abundance of Firmicutes (P 0.02 [Spearman’s rank correlation]) and increased relative
abundance of Bacteroidetes (P 0.01; not signiﬁcant for mouse samples) (Fig. 8A and B).
However, no correlation was observed between 16S rRNA transcript numbers and
phylum relative abundances in RNA isolates (P 0.05; Fig. 8C and D), indicating that
absolute bacterial densities in human gastric aspirate and mouse whole-stomach
samples have a signiﬁcant impact on the relative taxonomic composition of the total
(i.e., DNA-based) gastric microbiota but not the transcriptionally active (i.e., RNA-based)
gastric microbiota.
DISCUSSION
We identiﬁed a stomach-speciﬁc microbiota of increased microbial diversity and
altered taxonomic composition compared to esophagus but not duodenum. Within the
stomach, our analysis of the mucosal microbiota showed marginal compositional
variation between cardia, corpus, and antrum, despite well-known differences in his-
tological organization and pathological relevance between these sites (45). However,
FIG 7 DNA- and RNA-based relative and quantitative taxonomic microbiota compositions of human gastric aspirate (n  7) and mouse stomach
(n 6) samples. (A) Comparison of phylum relative abundances in DNA (blue) and RNA (orange) extracts of all samples based on 16S rRNA gene
PCR and transcript RT-PCR amplicon sequencing (***, P 0.001; **, P 0.01 [Mann-Whitney U test]). (B) Comparison of bacterial phyla based on
the ratio of 16S rRNA transcripts to 16S rRNA genes per sample (*, P 0.05 [Kruskal-Wallis test]).
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increases and decreases in the relative abundances of speciﬁc bacteria in gastric biopsy
samples correlated with the distance from the esophagus along the GI axis, suggesting
that while the microbiota of the stomach is closely linked to the esophagus, it is also
gradually modulated during gastric passage. Interestingly, opposite effects were ob-
served for different bacterial taxa that are typically described as oral commensals (46,
47), including selective depletion of Streptococcus and enrichment of R. mucilaginosa
and Porphyromonas in the stomach, which highlights the need to differentiate among
FIG 8 Association of phylum relative abundance and absolute 16S rRNA gene and transcript copy number. Correlations are shown for the ﬁve most abundant
phyla, including Firmicutes (red), Bacteroidetes (orange), Actinobacteria (gray), Proteobacteria (light blue), and Fusobacteria (dark blue). (A and B) Correlation of
phylum relative abundance in DNA, based on 16S rRNA gene amplicon sequencing with bacterial 16S rRNA gene copy number in human gastric aspirate (A)
and mouse whole-stomach (B) samples. (C and D) Correlation of phylum relative abundance in RNA, based on 16S rRNA transcript amplicon sequencing and
bacterial 16S rRNA transcript number in human gastric aspirate (C) and mouse whole-stomach (D) samples. Correlation coefﬁcients (R) and signiﬁcance (P) were
calculated using Spearman’s rank correlation.
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speciﬁc microbial taxa when describing the effects of stomach passage on ingested
bacteria.
In our study, the observed microbiota modulation from esophagus to stomach was
attenuated or even reversed between stomach and duodenum, indicating that the
stomach might serve as a bottleneck for bacterial transit from the upper to the lower
GI tract. These ﬁndings are supported by a recent comparison of metabolically active
microbial communities from the upper GI tract, which demonstrated increased relative
abundances of Porphyromonas and Lachnospiraceae as well as decreased relative
abundances of Streptococcus in stomach compared to duodenal aspirates (48). In
addition to differences in histological architecture, physiological factors such as re-
duced acidity in the duodenum compared to in the stomach (pH6 versus pH1) (27)
or the presence of bile acids (49) could exert different effects on mucosal microbial
communities. We have previously demonstrated that pH and immunosuppression
correlate with alterations in gastric microbiota compositions (44), in line with studies
linking use of proton pump inhibitors to increased risk for C. difﬁcile infection (20).
Microbiota shifts between stomach and duodenum support the idea of a gastric role for
controlling access of ingested bacteria to the lower GI tract, which could reduce the risk
of pathogen infection (23) and result in oral strains surviving transit to the gut only in
small quantities (50). Intestinal colonization with speciﬁc opportunistic bacteria from
the salivary microbiota (e.g., Klebsiella spp.) can induce intestinal inﬂammation and has
been associated with inﬂammatory bowel diseases (51). Interference with the entire
stomach microbiome could therefore be one factor to explain previous reports of
altered lower GI tract microbiota compositions as a consequence of bariatric surgery
and gastric acid inhibition and could play a role with respect to the widely used but
poorly deﬁned concept of dysbiosis (52).
Previous studies have examined the extent to which the stomach harbors a speciﬁc,
residual microbiota that is distinct from those of adjacent sites. Oral commensal
bacteria are frequently identiﬁed in the stomach, and the stomach microbiota overlaps
those of the oro- and nasopharynx (40–43). A recent 16S rRNA transcript-based
microbiota survey suggested saliva as the source of bacteria in gastric aspirate and
biopsy samples, speciﬁc taxa of which were enriched in the stomach (48). Franzosa
et al. identiﬁed speciﬁc bacterial species (e.g., Streptococcus salivarius) in analyses of the
salivary microbiota and fecal metagenomic DNA and metatranscriptomic RNA from the
same individual, indicating that even live bacteria could transit from mouth to colon
and maintain transcriptional activity (50). Our ﬁndings of gradual microbiota changes
between esophagus and stomach and within the stomach support the model of a
continuous microbial ecosystem of the GI tract and emphasize the need for additional
system-wide studies of the GI microbiota.
As a proof of concept, we used a combination of qualitative and quantitative DNA-
and RNA-based taxonomic microbiota analyses to study the relationship of relative and
absolute bacterial densities and transcriptionally active bacterial microbiota compo-
nents in the stomach, which could be exemplary for other human microbiota studies,
particularly those addressing samples of low microbial biomass and unclear metabolic
activity. Consistent with previous studies on the stomach (30, 41, 43, 48, 53), we
demonstrated large interindividual variations in the relative abundances of the two
dominant taxa in the human and animal stomach (Firmicutes and Bacteroidetes). The
ratio of Streptococcus (Firmicutes) to Prevotella (Bacteroidetes) in the stomach mucosa
(corpus and antrum) has previously been negatively correlated with hiatal hernia length
(30), and reduced relative abundance of Firmicutes in esophageal biopsy samples was
previously shown to be associated with esophagitis and Barrett’s esophagus (54).
However, we found no association of either of the two bacterial groups with disease
status in human patients or other human, mouse, or gerbil background parameters. In
contrast, we provide evidence for differences in absolute bacterial loads being at least
partially responsible for the observed variations in relative abundance, with gastric
relative abundances of Bacteroidetes but not Firmicutes being positively correlated with
total bacterial density in the stomach. Extreme interindividual variation in the relative
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abundances of Firmicutes and Bacteroidetes from the fecal microbiota of healthy human
individuals was also reported from the U.S. Human Microbiome Project (55), suggesting
that similar non-disease-associated, intrinsic factors could also play a role in shaping the
intestinal microbiota.
The physiological roles of Firmicutes and Bacteroidetes in the stomach could be
further differentiated based on the comparison of DNA- and RNA-based relative
bacterial microbiota compositions. Using the 16S rRNA transcript-to-gene ratio as a
marker of transcriptional activity, Bacteroidetes and Firmicutes represent the lowest
(0.18) and highest (0.51) values, respectively, among the gastric phyla, suggesting
increased metabolic activity of Firmicutes compared to Bacteroidetes. It should be noted
that, on the basis of comparisons to Escherichia coli, which has been estimated to
contain 6,800 ribosomes and 12.4 rRNA genes per cell under conditions of growth at a
doubling time of 100 min (56), which corresponds to a 16S rRNA transcript-to-gene
ratio of 5 102, all gastric bacteria exhibit low transcriptional activity. While this
could attest to the harsh gastric conditions that might generally inhibit bacterial
transcriptional activity, the possibility cannot be ruled out that experimental bias led to
reduced yields of RNA compared to DNA. Together, our ﬁndings from the comparative
analyses of relative and absolute bacterial abundances and DNA- and RNA-based
relative compositions support a model of the stomach microbiota as being dominated
by transcriptionally more active Firmicutes but also as variably affected by additional,
temporal inﬂux of transcriptionally less active Bacteroidetes.
We found the overall microbiota similarity between stomach and esophagus, mea-
sured as taxonomic distance, to be positively correlated with gastric relative abun-
dances of Firmicutes. Inﬂux of Bacteroidetes would therefore have to originate from
naso- or oropharyngeal locations upstream of the esophagus or from the lower GI tract.
Bassis et al. identiﬁed the highest relative abundance of the Bacteroidetes genus
Prevotella in human oral wash samples compared to nasal swabs and bronchoalveolar
lavage ﬂuid and gastric aspirate samples (41). While those authors, in contrast to our
study, found no evidence of selective elimination of Prevotella in the stomach, this
analysis was performed on 16S rRNA gene-based relative abundance data. Longitudinal
sampling of the gastric and naso- and oropharyngeal microbiota in healthy individuals
will be needed to test for intraindividual temporal variations and interdependencies of
the stomach and esophagus microbiota and to identify the potential source of Bacte-
roidetes in the stomach.
Mice and gerbils are two widely used models to study human stomach pathologies
(57). Our gastric microbiota comparisons revealed that humans, mice, and gerbils are
dominated by the same two bacterial phyla, classes, and orders. However, the stomach
microbiotas of the two rodent species differ from those of humans at the taxonomic
family and genus level, which, in light of phenotypic differences in colonization
resistance and pathology of mice and gerbils infected with human isolates of H. pylori
(58), highlights the need for further studies on the functional relevance of these
taxonomic differences.
In conclusion, despite the limitations of the present study, including relatively small
sample sizes, we demonstrated the feasibility of combined qualitative and quantitative
DNA- and RNA-based microbiota analyses for the stomach, which we found (i) to be
closely related to microbial communities from upstream GI locations, (ii) to selectively
enrich and deplete speciﬁc bacterial taxa during their passage to the duodenum, and
(iii) to be shaped by transcriptionally more active Firmicutes and less active Bacteroidetes
that increase in relative abundance with total bacterial stomach load.
MATERIALS AND METHODS
Human study cohort and sample collection. Gastrointestinal biopsy samples and aspirate samples
were collected at the Medical University of Graz (Graz, Austria) from 24 individuals who underwent upper
endoscopy for various clinical indications (Table 1; see also Table S1 in the supplemental material). The
Institutional Review Board of the Medical University of Graz approved the study under protocol number
EK 23-212 ex 10/11, and all subjects provided written informed consent to participate in the study.
Endoscopic and histologic reports indicated no or minimal evidence of GI pathology in 15 patients and
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gastritis in 8 patients (H. pylori-associated gastritis, 2 patients; atrophic autoimmune gastritis, 2 patients;
other gastritis, 4 patients). One patient had Crohn’s disease. Biopsy samples were obtained by routine
esophagogastroduodenoscopy by a gastroenterologist (C. Högenauer). The samples were taken in the
following order: (i) duodenum, (ii) gastric ﬂuid, (iii) antrum, (iv) corpus, (v) cardia, (vi) esophagus. Biopsy
samples were immediately transferred to RNAlater (Qiagen), and gastric aspirate samples for qualitative
microbiota analysis were diluted at a ratio of 1:1 in 0.5 ml RNAlater and stored at80°C. Aspirate samples
for quantitative microbiota analysis were stored on ice for 30 min and centrifuged for 15 min at 13,200
rpm (4°C), and the resulting pellets were diluted with 400 to 800 l RNAlater. Samples from the primary
patient cohort were shipped on dry ice to the Institute for Genome Sciences of the University of Maryland
School of Medicine (Baltimore, MD) for processing and sequencing. Gastric aspirate samples from the
seven patients who participated in the proof-of-concept study were shipped on dry ice to the University
of Hohenheim, Stuttgart, Germany. All samples were stored at 80°C until processing.
Animal sample collection. C57BL/6 mice were ordered from the Jackson Laboratory, Bar Harbor, ME,
and used to extract stomach samples within 5 days after delivery at the University of Maryland, Baltimore.
Mongolian gerbil stomach samples were collected at the Max von Pettenkofer-Institute in Munich,
Germany. Samples from 10 mice and 10 gerbils were collected as follows. The animals were euthanized,
and complete stomachs, including the forestomach, were extracted, cut in half at the curvatura gastrica
major, and immediately transferred to RNAlater. Gerbil samples were shipped at room temperature to the
University of Maryland, Baltimore. All samples were stored at 80°C upon arrival at the Institute for
Genome Sciences, University of Maryland, Baltimore, until processing. For the proof-of-concept study,
whole-stomach samples from six C57B46J mice from the animal care facility at the University of
Hohenheim were harvested and stored as described above. However, loose stomach content was
removed and the remaining stomach tissue cut into two halves, which were used as technical replicates
for downstream processing and analyses.
DNA and RNA extraction. Metagenomic DNA was isolated from all samples using a previously
described protocol (44), which includes both enzymatic digestions (lysozyme, mutanolysin, lysostaphin,
proteinase K, and RNase) and mechanical disruption by bead beating. Brieﬂy, stomach and biopsy
samples were subjected to vortex mixing at full speed for 3 min, and the entirety of the ﬂuid was
transferred to new tubes. Samples were centrifuged at 13,200 rpm for 10 min, the supernatant was
discarded, and the pellets were resuspended in phosphate-buffered saline (PBS) for enzymatic and
mechanical lysis. Hypervariable regions V1 to V3 of the bacterial 16S rRNA gene were ampliﬁed using
barcoded primers 27F and 534R with Roche/454 adaptors and puriﬁed amplicon mixtures sequenced at
the Institute for Genome Sciences, University of Maryland, using 454 primer A and protocols recom-
mended by the manufacturer (Roche), as described previously (59).
For the proof-of-concept study, DNA and RNA were extracted simultaneously by the use of a
ZymoBIOMICS DNA/RNA Miniprep kit (Zymo Research). Human aspirate and mouse samples were
subjected to vortex mixing for 5 min at 4°C. Two aliquots of 2 to 4 ml of gastric aspirate were used as
technical replicates for extraction and centrifuged at 15,000  g for 10 min at 4°C. The luminal side of
the mouse stomach tissue was rinsed with 1 ml PBS, and the ﬂuid was centrifuged at 15,000  g for
10 min at 4°C All pellets were washed twice with PBS, resolved in 800 l of ZymoBIOMICS DNA/RNA lysis
buffer, transferred to MP-Lysing matrix tube B (MP Biomedicals), and stored on ice for 5 min. Samples
were lysed mechanically by bead beating at 6 m/s for 45 s twice, with intermediate storage on ice for
5 min. The lysate was used as input for the ZymoBIOMICS DNA/RNA Miniprep kit following the
manufacture’s recommendations with modiﬁcations as follows. The RNA fraction of the samples was
treated with DNase I at 37°C for 30 min; DNA and RNA were washed twice with 400 l wash buffer before
elution in 30 to 35 l DNase/RNase-free water. DNA was stored at 20°C and RNA at 80°C until further
processing. Potential additional DNA contamination in RNA isolates was further digested by the use of
a Turbo DNA-free kit (Thermo Fisher Scientiﬁc).
16S rRNA gene and transcript ampliﬁcation and sequencing. RNA was reverse transcribed with
primer 1492R (l) primer, using a GoScript reverse transcriptase kit (Promega). In brief, 3.5 l of the
DNA-free RNA was incubated with 1.5 l primer (15 pmol) for 5 min at 70°C and immediately chilled in
ice water for 5 min. A reverse transcription reaction mixture, containing 4 l GoScript 5 reaction buffer,
2.8 l MgCl2 (3.5 mM), 1 l PCR nucleotide mix (0.5 mM for each deoxynucleoside triphosphate [dNTP];
Thermo Fisher Scientiﬁc), 1 l GoScript reverse transcriptase, and 6.2 l nuclease-free water. Reactions
were annealed at 25°C for 5 min, followed by extension at 42°C for 1 h and reverse transcriptase
inactivation at 70°C for 15 min. The cDNA was cleaned using a DNA Clean and Concentrator 5 kit (Zymo
Research) according to the manufacturer’s recommendations.
Metagenomic DNA and cDNA were used as templates for PCR ampliﬁcation of hypervariable region
V4 of the bacterial 16S rRNA gene, using Phusion High-Fidelity PCR Master Mix (Thermo Fisher Scientiﬁc)
and Golay-barcoded primers 515F and 806R adapted from Caporaso et al. (60), including internal spacers
of 0 to 7 bp in length adapted from the method described by Fadrosh et al. (61). See Table S3 for primer,
barcode, and spacer sequences.
PCRs were carried out with reaction mixtures containing 10 l 2 Phusion Master Mix, 5 l of each
of the primers (1.6 M ﬁnal concentration), 0.6 l dimethyl sulfoxide (DMSO), and 4.4 l template DNA
at 98°C for 2 min, with 30 cycles at 98°C for 10 s, 52°C for 15 s, and 72°C for 15 s and a ﬁnal extension at
72°C for 5 min.
Equimolar amounts of all PCR products were prepared using SequalPrep normalization plate kit 96
(Thermo Fisher Scientiﬁc) and were pooled and concentrated using a DNA Clean and Concentrator 5 kit
(Zymo Research). Sequencing libraries were prepared with a NEBNext Ultra DNA library preparation kit
(New England Biolabs) and sequenced following the manufacturer’s recommendations on an Illumina
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MiSeq instrument (MiSeq Reagent kit v3; 600 cycles) at the University of Hohenheim, Hohenheim,
Germany.
Quantitative 16S rRNA gene and transcript ampliﬁcations. To determine bacterial loads in human
aspirate and mouse stomach samples, metagenomic DNA and cDNA were diluted 1:100 and duplicates
of 2 l used as the template for quantitative PCR with a Femto bacterial DNA quantiﬁcation kit (Zymo
Research), according to the manufacturer’s recommendations. Genomic DNA from E. coli strain JM109,
which is part of the kit and contains seven 16S rRNA gene copies per genome, was used as an internal
standard to estimate bacterial 16S rRNA gene or transcript copy numbers. The reactions were run on a
CFX96 Touch real-time detection system (Bio-Rad). See Table S2 for protocol details. Samples were
considered negative if the quantiﬁcation cycle number was greater than 39. An average quantiﬁcation
cycle (Cq) value was calculated for each sample and used for determination of the numbers of 16S gene
copies and transcripts. The estimated bacterial 16S rRNA gene or transcript copy numbers were
calculated as averages from the two technical replicates and normalized to 1 ml of human gastric
aspirate and the entire stomach of one mouse (Table S2).
Microbiota analysis and statistical methods. Raw sequence data from the Roche/454 GS FLX
Titanium platform were processed with Mothur (62) according to the standard operating procedure for
454 sequence data (https://mothur.org/wiki/454_SOP [63]) with additional removal of singletons. Sub-
sequent OTU-based microbiota analyses were performed in QIIME v1.8.0 (64), including OTU clustering
with 97% similarity, rarefaction to a sampling depth of 1,415 reads (human aspirate, gerbil and mouse
samples) or 880 reads (all human and animal samples) per sample, and alpha- and beta-diversity
analyses. Differences in taxonomic microbiota compositions between groups were analyzed with the
linear discriminant analysis effect size (LEfSe) algorithm (65). For the proof-of-concept study, raw
sequence data from the Illumina MiSeq platform were preprocessed with QIIME v. 1.9.1 and cutadapt
(66), including extraction of barcodes, merging of read pairs, and demultiplexing and trimming of spacers
and primers. OTUs were generated based on a similarity threshold of 95%, and samples were rareﬁed to
10,000 reads per sample.
The speciﬁc statistics tests used to determine signiﬁcance are listed in ﬁgure legends. P values below
0.05 were considered signiﬁcant (*, P 0.05; **, P 0.01; ***, P 0.001). Unless indicated differently,
mean values are presented together with standard errors of the means (SEM). Detailed information about
all bioinformatic scripts and commands used is provided in Table S3.
Ethics approval and consent to participate. The Institutional Review Board of the Medical
University of Graz approved the study under protocol number EK 23-212 ex 10/11, and all subjects
provided written informed consent to participate in the study. All experimental procedures related to the
Mongolian gerbils were carried out at the Ludwig-Maximilians-University of Munich in accordance with
the German Law of Animal Welfare and approved by the Regierung of Oberbayern, Oberbayern,
Germany (AZ 55.2-1-54-2532-1-2011). Procedures performed on mice were approved by the Institutional
Animal Care and Use Committee of the University of Maryland in Baltimore (protocol 0812002) or were
carried out at the University of Hohenheim in accordance with the German Law of Animal Welfare.
Availability of data and material. Raw sequence ﬁles have been deposited in the European
Nucleotide Archive under primary accession number PRJEB11744 (secondary accession number
ERP013156).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSystems.00262-18.
FIG S1, TIF ﬁle, 0.2 MB.
FIG S2, TIF ﬁle, 0.5 MB.
FIG S3, TIF ﬁle, 1.4 MB.
FIG S4, TIF ﬁle, 1 MB.
FIG S5, TIF ﬁle, 0.5 MB.
FIG S6, TIF ﬁle, 0.2 MB.
TABLE S1, XLSX ﬁle, 0.1 MB.
TABLE S2, XLSX ﬁle, 1 MB.
TABLE S3, XLSX ﬁle, 0.03 MB.
ACKNOWLEDGMENTS
We declare that we have no competing interests.
The work was supported by the Austrian Science Fund (FWF W1241-B18), Bio-
TechMed Graz, the Medical University of Graz (DK-MOLIN), and the Carl-Zeiss-Stiftung/
German Scholars Organization e.V. (Wissenschaftler-Rückkehrprogramm GSO/CZS).
E.D., C.M., U.H., and T.B. carried out the sample handling. E.D. and C.M. processed the
samples, isolated DNA, and ran 16S rRNA ampliﬁcations. P.W., E.D., and B.H. processed
the sequence data. P.W., C.K., and J.S. performed the statistical analysis. C.H. and G.G.
obtained clinical samples and metadata. U.H., T.B., and R.H. obtained animal samples
and metadata. G.G. and W.F.F. conceived, designed, and coordinated the study. P.W.,
Biogeography of the Stomach Microbiota
November/December 2018 Volume 3 Issue 6 e00262-18 msystems.asm.org 15
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
E.D., G.G., and W.F.F. wrote the manuscript. All of us read and approved the ﬁnal
manuscript.
REFERENCES
1. Hsiao A, Ahmed AM, Subramanian S, Grifﬁn NW, Drewry LL, Petri WA, Jr,
Haque R, Ahmed T, Gordon JI. 2014. Members of the human gut
microbiota involved in recovery from Vibrio cholerae infection. Nature
515:423–426. https://doi.org/10.1038/nature13738.
2. Bufﬁe CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D,
Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MR, Jenq RR,
Taur Y, Sander C, Cross JR, Toussaint NC, Xavier JB, Pamer EG. 2015.
Precision microbiome reconstitution restores bile acid mediated re-
sistance to Clostridium difﬁcile. Nature 517:205–208. https://doi.org/
10.1038/nature13828.
3. Maier L, Vyas R, Cordova CD, Lindsay H, Schmidt TS, Brugiroux S,
Periaswamy B, Bauer R, Sturm A, Schreiber F, von Mering C, Robinson
MD, Stecher B, Hardt WD. 2013. Microbiota-derived hydrogen fuels
Salmonella typhimurium invasion of the gut ecosystem. Cell Host Mi-
crobe 14:641–651. https://doi.org/10.1016/j.chom.2013.11.002.
4. Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M,
Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B,
Wilmes P, Stappenbeck TS, Nunez G, Martens EC. 2016. A dietary ﬁber-
deprived gut microbiota degrades the colonic mucus barrier and en-
hances pathogen susceptibility. Cell 167:1339–1353.E21. https://doi.org/
10.1016/j.cell.2016.10.043.
5. Sonnenburg JL, Backhed F. 2016. Diet-microbiota interactions as mod-
erators of human metabolism. Nature 535:56–64. https://doi.org/10
.1038/nature18846.
6. Greer RL, Dong X, Moraes AC, Zielke RA, Fernandes GR, Peremyslova E,
Vasquez-Perez S, Schoenborn AA, Gomes EP, Pereira AC, Ferreira SR, Yao
M, Fuss IJ, Strober W, Sikora AE, Taylor GA, Gulati AS, Morgun A,
Shulzhenko N. 2016. Akkermansia muciniphila mediates negative effects
of IFNgamma on glucose metabolism. Nat Commun 7:13329. https://doi
.org/10.1038/ncomms13329.
7. Mahana D, Trent CM, Kurtz ZD, Bokulich NA, Battaglia T, Chung J, Muller
CL, Li H, Bonneau RA, Blaser MJ. 2016. Antibiotic perturbation of the
murine gut microbiome enhances the adiposity, insulin resistance, and
liver disease associated with high-fat diet. Genome Med 8:48. https://
doi.org/10.1186/s13073-016-0297-9.
8. Thaiss CA, Zmora N, Levy M, Elinav E. 2016. The microbiome and innate
immunity. Nature 535:65–74. https://doi.org/10.1038/nature18847.
9. Livanos AE, Greiner TU, Vangay P, Pathmasiri W, Stewart D, McRitchie S,
Li H, Chung J, Sohn J, Kim S, Gao Z, Barber C, Kim J, Ng S, Rogers AB,
Sumner S, Zhang XS, Cadwell K, Knights D, Alekseyenko A, Backhed F,
Blaser MJ. 2016. Antibiotic-mediated gut microbiome perturbation ac-
celerates development of type 1 diabetes in mice. Nat Microbiol 1:16140.
https://doi.org/10.1038/nmicrobiol.2016.140.
10. Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, Panzer AR,
LaMere B, Rackaityte E, Lukacs NW, Wegienka G, Boushey HA, Ownby DR,
Zoratti EM, Levin AM, Johnson CC, Lynch SV. 2016. Neonatal gut micro-
biota associates with childhood multisensitized atopy and T cell differ-
entiation. Nat Med 22:1187–1191. https://doi.org/10.1038/nm.4176.
11. Garrett WS. 2015. Cancer and the microbiota. Science 348:80–86.
https://doi.org/10.1126/science.aaa4972.
12. Zackular JP, Baxter NT, Chen GY, Schloss PD. 2016. Manipulation of the
gut microbiota reveals role in colon tumorigenesis. mSphere 1:e00001
-15. https://doi.org/10.1128/mSphere.00001-15.
13. Vuong HE, Yano JM, Fung TC, Hsiao EY. 2017. The microbiome and host
behavior. Annu Rev Neurosci 40:21–49. https://doi.org/10.1146/annurev
-neuro-072116-031347.
14. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W,
Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic
AD, Luo C, Gonzalez A, McDonald D, Haberman Y, Walters T, Baker S,
Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Grifﬁths
A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C,
Knight R, Xavier RJ. 2014. The treatment-naive microbiome in new-
onset Crohn’s disease. Cell Host Microbe 15:382–392. https://doi.org/
10.1016/j.chom.2014.02.005.
15. Lavelle A, Lennon G, O’Sullivan O, Docherty N, Balfe A, Maguire A,
Mulcahy HE, Doherty G, O’Donoghue D, Hyland J, Ross RP, Coffey JC,
Sheahan K, Cotter PD, Shanahan F, Winter DC, O’Connell PR. 2015.
Spatial variation of the colonic microbiota in patients with ulcerative
colitis and control volunteers. Gut 64:1553–1561. https://doi.org/10
.1136/gutjnl-2014-307873.
16. Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, Wurm
P, Gorkiewicz G, Hogenauer C, Pieber TR. 2016. Effects of high doses of
vitamin D3 on mucosa-associated gut microbiome vary between regions
of the human gastrointestinal tract. Eur J Nutr 55:1479–1489. https://
doi.org/10.1007/s00394-015-0966-2.
17. Liou AP, Paziuk M, Luevano JM, Jr, Machineni S, Turnbaugh PJ, Kaplan
LM. 2013. Conserved shifts in the gut microbiota due to gastric bypass
reduce host weight and adiposity. Sci Transl Med 5:178ra41. https://doi
.org/10.1126/scitranslmed.3005687.
18. Tremaroli V, Karlsson F, Werling M, Ståhlman M, Kovatcheva-Datchary
P, Olbers T, Fändriks L, Le Roux CW, Nielsen J, Bäckhed F. 2015.
Roux-en-Y gastric bypass and vertical banded gastroplasty induce
long-term changes on the human gut microbiome contributing to fat
mass regulation. Cell Metab 22:228–238. https://doi.org/10.1016/j
.cmet.2015.07.009.
19. Palleja A, Kashani A, Allin KH, Nielsen T, Zhang C, Li Y, Brach T, Liang S,
Feng Q, Jorgensen NB, Bojsen-Moller KN, Dirksen C, Burgdorf KS, Holst
JJ, Madsbad S, Wang J, Pedersen O, Hansen T, Arumugam M. 2016.
Roux-en-Y gastric bypass surgery of morbidly obese patients induces
swift and persistent changes of the individual gut microbiota. Genome
Med 8:67. https://doi.org/10.1186/s13073-016-0312-1.
20. McDonald EG, Milligan J, Frenette C, Lee TC. 2015. Continuous proton
pump inhibitor therapy and the associated risk of recurrent Clostridium
difﬁcile infection. JAMA Intern Med 175:784–791. https://doi.org/10
.1001/jamainternmed.2015.42.
21. Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, Tigchelaar EF,
Jankipersadsing SA, Cenit MC, Harmsen HJ, Dijkstra G, Franke L, Xavier
RJ, Jonkers D, Wijmenga C, Weersma RK, Zhernakova A. 2016. Proton
pump inhibitors affect the gut microbiome. Gut 65:740–748. https://doi
.org/10.1136/gutjnl-2015-310376.
22. Freedberg DE, Toussaint NC, Chen SP, Ratner AJ, Whittier S, Wang TC,
Wang HH, Abrams JA. 2015. Proton pump inhibitors alter speciﬁc taxa in
the human gastrointestinal microbiome: a crossover trial. Gastroenter-
ology 149:883–885.e9. https://doi.org/10.1053/j.gastro.2015.06.043.
23. Yang I, Nell S, Suerbaum S. 2013. Survival in hostile territory: the micro-
biota of the stomach. FEMS Microbiol Rev 37:736–761. https://doi.org/
10.1111/1574-6976.12027.
24. Li XX, Wong GL, To KF, Wong VW, Lai LH, Chow DK, Lau JY, Sung JJ, Ding
C. 2009. Bacterial microbiota proﬁling in gastritis without Helicobacter
pylori infection or non-steroidal anti-inﬂammatory drug use. PLoS One
4:e7985. https://doi.org/10.1371/journal.pone.0007985.
25. Engstrand L, Lindberg M. 2013. Helicobacter pylori and the gastric
microbiota. Best Pract Res Clin Gastroenterol 27:39–45. https://doi.org/
10.1016/j.bpg.2013.03.016.
26. Delgado S, Cabrera-Rubio R, Mira A, Suárez A, Mayo B. 2013. Microbio-
logical survey of the human gastric ecosystem using culturing and
pyrosequencing methods. Microb Ecol 65:763–772. https://doi.org/10
.1007/s00248-013-0192-5.
27. Fallingborg J. 1999. Intraluminal pH of the human gastrointestinal tract.
Dan Med Bull 46:183–196.
28. Rindi G, Leiter AB, Kopin AS, Bordi C, Solcia E. 2004. The 	normal	
endocrine cell of the gut: changing concepts and new evidences. Ann N
Y Acad Sci 1014:1–12. https://doi.org/10.1196/annals.1294.001.
29. Jager S, Stange EF, Wehkamp J. 2010. Antimicrobial peptides in gastro-
intestinal inﬂammation. Int J Inﬂam 2010:910283. https://doi.org/10
.4061/2010/910283.
30. Gall A, Fero J, McCoy C, Claywell BC, Sanchez CA, Blount PL, Li X,
Vaughan TL, Matsen FA, Reid BJ, Salama NR. 2015. Bacterial composition
of the human upper gastrointestinal tract microbiome is dynamic and
associated with genomic instability in a Barrett’s esophagus cohort. PLoS
One 10:e0129055. https://doi.org/10.1371/journal.pone.0129055.
31. Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A,
Torres J. 2014. Stomach microbiota composition varies between patients
Wurm et al.
November/December 2018 Volume 3 Issue 6 e00262-18 msystems.asm.org 16
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
with non-atrophic gastritis and patients with intestinal type of gastric
cancer. Sci Rep 4:4202. https://doi.org/10.1038/srep04202.
32. Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER,
Feng Y, Ge Z, Wang TC, Fox JG. 2014. Gastric colonisation with a
restricted commensal microbiota replicates the promotion of neoplastic
lesions by diverse intestinal microbiota in the Helicobacter pylori INS-
GAS mouse model of gastric carcinogenesis. Gut 63:54–63. https://doi
.org/10.1136/gutjnl-2013-305178.
33. Nardone G, Compare D, Rocco A. 2017. A microbiota-centric view of
diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepa-
tol 2:298–312. https://doi.org/10.1016/S2468-1253(16)30108-X.
34. Hunt RH, Yaghoobi M. 2017. The esophageal and gastric microbiome in
health and disease. Gastroenterol Clin North Am 46:121–141. https://doi
.org/10.1016/j.gtc.2016.09.009.
35. Zhang S, Moss SF. 2012. Rodent models of Helicobacter infection, in-
ﬂammation, and disease. Methods Mol Biol 921:89–98. https://doi.org/
10.1007/978-1-62703-005-2_12.
36. San Roman AK, Shivdasani RA. 2011. Boundaries, junctions and transi-
tions in the gastrointestinal tract. Exp Cell Res 317:2711–2718. https://
doi.org/10.1016/j.yexcr.2011.07.011.
37. Sung J, Kim N, Kim J, Jo HJ, Park JH, Nam RH, Seok YJ, Kim YR, Lee DH,
Jung HC. 2016. Comparison of gastric microbiota between gastric juice
and mucosa by next generation sequencing method. J Cancer Prev
21:60–65. https://doi.org/10.15430/JCP.2016.21.1.60.
38. Llorca L, Perez-Perez G, Urruzuno P, Martinez MJ, Iizumi T, Gao Z, Sohn
J, Chung J, Cox L, Simon-Soro A, Mira A, Alarcon T. 2016. Characterization
of the gastric microbiota in a pediatric population according to Helico-
bacter pylori status. Pediatr Infect Dis J 36:173–178.
39. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Con-
treras M, Blaser MJ, Brodie EL, Dominguez-Bello MG. 2011. Structure of
the human gastric bacterial community in relation to Helicobacter pylori
status. ISME J 5:574–579. https://doi.org/10.1038/ismej.2010.149.
40. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-
Perez G, Blaser MJ, Relman DA. 2006. Molecular analysis of the bacterial
microbiota in the human stomach. Proc Natl Acad Sci U S A 103:732–737.
https://doi.org/10.1073/pnas.0506655103.
41. Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM,
Young VB, Beck JM, Curtis JL, Huffnagle GB. 2015. Analysis of the upper
respiratory tract microbiotas as the source of the lung and gastric
microbiotas in healthy individuals. mBio 6:e00037-15. https://doi.org/10
.1128/mBio.00037-15.
42. Tsuda A, Suda W, Morita H, Takanashi K, Takagi A, Koga Y, Hattori M.
2015. Inﬂuence of proton-pump inhibitors on the luminal microbiota in
the gastrointestinal tract. Clin Transl Gastroenterol 6:e89. https://doi.org/
10.1038/ctg.2015.20.
43. Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand
L. 2008. Comparative analysis of human gut microbiota by barcoded
pyrosequencing. PLoS One 3:e2836. https://doi.org/10.1371/journal
.pone.0002836.
44. von Rosenvinge EC, Song Y, White JR, Maddox C, Blanchard T, Fricke WF.
2013. Immune status, antibiotic medication and pH are associated with
changes in the stomach ﬂuid microbiota. ISME J 7:1354–1366. https://
doi.org/10.1038/ismej.2013.33.
45. Owen DA. 1986. Normal histology of the stomach. Am J Surg Pathol
10:48–61. https://doi.org/10.1097/00000478-198601000-00006.
46. Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall AB, Brady
A, Creasy HH, McCracken C, Giglio MG, McDonald D, Franzosa EA, Knight
R, White O, Huttenhower C. 2017. Strains, functions and dynamics in the
expanded Human Microbiome Project. Nature 550:61–66. https://doi
.org/10.1038/nature23889.
47. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan
A, Wade WG. 2010. The human oral microbiome. J Bacteriol 192:
5002–5017. https://doi.org/10.1128/JB.00542-10.
48. Schulz C, Schutte K, Koch N, Vilchez-Vargas R, Wos-Oxley ML, Oxley AP,
Vital M, Malfertheiner P, Pieper DH. 2018. The active bacterial assem-
blages of the upper GI tract in individuals with and without Helicobacter
infection. Gut 67:216–225. https://doi.org/10.1136/gutjnl-2016-312904.
49. Schubert K, Olde Damink SWM, von Bergen M, Schaap FG. 2017. Inter-
actions between bile salts, gut microbiota, and hepatic innate immunity.
Immunol Rev 279:23–35. https://doi.org/10.1111/imr.12579.
50. Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, Gian-
noukos G, Boylan MR, Ciulla D, Gevers D, Izard J, Garrett WS, Chan AT,
Huttenhower C. 2014. Relating the metatranscriptome and metagenome
of the human gut. Proc Natl Acad Sci U S A 111:E2329–E2338. https://
doi.org/10.1073/pnas.1319284111.
51. Atarashi K, Suda W, Luo C, Kawaguchi T, Motoo I, Narushima S, Kiguchi
Y, Yasuma K, Watanabe E, Tanoue T, Thaiss CA, Sato M, Toyooka K, Said
HS, Yamagami H, Rice SA, Gevers D, Johnson RC, Segre JA, Chen K, Kolls
JK, Elinav E, Morita H, Xavier RJ, Hattori M, Honda K. 2017. Ectopic
colonization of oral bacteria in the intestine drives TH1 cell induction
and inﬂammation. Science 358:359–365. https://doi.org/10.1126/science
.aan4526.
52. Vangay P, Ward T, Gerber JS, Knights D. 2015. Antibiotics, pediatric
dysbiosis, and disease. Cell Host Microbe 17:553–564. https://doi.org/10
.1016/j.chom.2015.04.006.
53. Dicksved J, Lindberg M, Rosenquist M, Enroth H, Jansson JK, Engstrand
L. 2009. Molecular characterization of the stomach microbiota in pa-
tients with gastric cancer and in controls. J Med Microbiol 58:509–516.
https://doi.org/10.1099/jmm.0.007302-0.
54. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. 2009. Inﬂammation
and intestinal metaplasia of the distal esophagus are associated with
alterations in the microbiome. Gastroenterology 137:588–597. https://
doi.org/10.1053/j.gastro.2009.04.046.
55. Human Microbiome Project Consortium. 2012. Structure, function and
diversity of the healthy human microbiome. Nature 486:207–214.
https://doi.org/10.1038/nature11234.
56. Bremer H, Dennis PP. 1996. Modulation of chemical composition and
other parameters of the cell by growth rate, p 1559. In Neidhardt FC,
Curtiss R, III, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS,
Riley M, Schaechter M, Umbarger HE (ed), Escherichia coli and
Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Wash-
ington, DC.
57. Tsukamoto T, Mizoshita T, Tatematsu M. 2007. Animal models of stom-
ach carcinogenesis. Toxicol Pathol 35:636–648. https://doi.org/10.1080/
01926230701420632.
58. Farnbacher M, Jahns T, Willrodt D, Daniel R, Haas R, Goesmann A, Kurtz
S, Rieder G. 2010. Sequencing, annotation, and comparative genome
analysis of the gerbil-adapted Helicobacter pylori strain B8. BMC Genom-
ics 11:335. https://doi.org/10.1186/1471-2164-11-335.
59. Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta
S, Fricke WF. 2013. Microbiota dynamics in patients treated with fecal
microbiota transplantation for recurrent Clostridium difﬁcile infection.
PLoS One 8:e81330. https://doi.org/10.1371/journal.pone.0081330.
60. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA,
Turnbaugh PJ, Fierer N, Knight R. 2011. Global patterns of 16S rRNA
diversity at a depth of millions of sequences per sample. Proc Natl
Acad Sci U S A 108(Suppl 1):4516–4522. https://doi.org/10.1073/pnas
.1000080107.
61. Fadrosh DW, Ma B, Gajer P, Sengamalay N, Ott S, Brotman RM, Ravel J.
2014. An improved dual-indexing approach for multiplexed 16S rRNA
gene sequencing on the Illumina MiSeq platform. Microbiome 2:6.
https://doi.org/10.1186/2049-2618-2-6.
62. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB,
Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B,
Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-
source, platform-independent, community-supported software for de-
scribing and comparing microbial communities. Appl Environ Microbiol
75:7537–7541. https://doi.org/10.1128/AEM.01541-09.
63. Schloss PD, Gevers D, Westcott SL. 2011. Reducing the effects of PCR
ampliﬁcation and sequencing artifacts on 16S rRNA-based studies. PLoS
One 6:e27310. https://doi.org/10.1371/journal.pone.0027310.
64. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD,
Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley
ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD,
Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J,
Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of
high-throughput community sequencing data. Nat Methods 7:335–336.
https://doi.org/10.1038/nmeth.f.303.
65. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS,
Huttenhower C. 2011. Metagenomic biomarker discovery and explana-
tion. Genome Biol 12:R60. https://doi.org/10.1186/gb-2011-12-6-r60.
66. Martin M. 2011. Cutadapt removes adapter sequences from high-
throughput sequencing reads. EMBnet J 17:10–12. https://doi.org/10
.14806/ej.17.1.200.
Biogeography of the Stomach Microbiota
November/December 2018 Volume 3 Issue 6 e00262-18 msystems.asm.org 17
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
